Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: 5-Year Randomized Trial Results

Volume: 122, Issue: 2, Pages: 375 - 381
Published: Feb 1, 2015
Abstract
Objective null To report the 3-year follow-up results within a previously reported randomized trial evaluating prompt versus deferred (for ≥24 weeks) focal/grid laser treatment in eyes treated with intravitreal 0.5 mg ranibizumab for diabetic macular edema (DME). null Design null Multicenter, randomized clinical trial. null Participants null Three hundred sixty-one participants with visual acuity of 20/32 to 20/320 (approximate Snellen...
Paper Details
Title
Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: 5-Year Randomized Trial Results
Published Date
Feb 1, 2015
Volume
122
Issue
2
Pages
375 - 381
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.